Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06010251 · ClinicalTrials.gov registry record · NA

Utility of Multisensory Body-Representation in Spinal Cord Injury (SCI) With Pain

A NA study of Spinal Cord Injuries and Neuropathic Pain, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06010251 is a NA study of Spinal Cord Injuries and Neuropathic Pain that is actively recruiting participants, run by University of Miami. The registered enrollment target is 30 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06010251, a NA study of Spinal Cord Injuries and Neuropathic Pain, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the effectiveness of bodily illusions combined with transcranial direct current stimulation (tDCS) on neuropathic pain symptoms and sensory functions in participants with spinal cord injury (SCI) and neuropathic pain.

Interventions

  • OTHER tDCS and bodily illusions

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-10-17
Est. Completion 2026-10-20
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06010251

The ClinicalTrials.gov registry entry for NCT06010251 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (51% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which tDCS and bodily illusions is the first listed.

NCT06010251 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06010251 about?

NCT06010251 is a clinical study titled "Utility of Multisensory Body-Representation in Spinal Cord Injury (SCI) With Pain". The purpose of this study is to investigate the effectiveness of bodily illusions combined with transcranial direct current stimulation (tDCS) on neuropathic pain symptoms and sensory functions in participants with spinal cord injury (SCI) and neuropathic pain.

What is the current status of trial NCT06010251?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-10-17. Estimated completion is 2026-10-20.

What conditions does trial NCT06010251 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Neuropathic Pain.

What interventions are being tested in trial NCT06010251?

The interventions under investigation include: tDCS and bodily illusions (OTHER).

Who is sponsoring clinical trial NCT06010251?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06010251 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.